<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-982
Date of Submission: 2024-08-29

This report was submitted by a Patient from Rhodes-Lane Medical Center concerning patient ANON-PX-3571. The subject is a 51-year-old male with a significant medical history including type 2 diabetes, anxiety, atrial fibrillation, hypertension. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Levothyroxine administered via the Subcutaneous route at a dosage of 432mg, initiated on 2024-06-28 for Hypothyroidism with the course ongoing.

On approximately 2024-07-24, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Dizziness, Nausea. The Dizziness was classified as Severe in severity. This necessitated clinical intervention. The documented action was: Prescribed beautiful and advised must. The current patient status regarding this symptom is 'Unknown'. The Nausea was classified as Mild in severity. This necessitated clinical intervention. The documented action was: Prescribed right and advised market. The current patient status regarding this symptom is 'Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Negative dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

</data>
report_id: ADR-2024-982
report_date: '2024-08-29'
patient_details:
  patient_id: ANON-PX-3571
  gender: Male
  relevant_history:
  - type 2 diabetes
  - anxiety
  - atrial fibrillation
  - hypertension
  age_at_reaction: 51
suspected_drugs:
- drug_name: Levothyroxine
  dosage: 432mg
  route_of_administration: Subcutaneous
  start_date: '2024-06-28'
  indication_for_use: Hypothyroidism
adverse_reactions:
- symptom_name: Dizziness
  onset_date: '2024-07-24'
  severity: Severe
  outcome: Unknown
  intervention_required: true
  intervention_details: Prescribed beautiful and advised must.
- symptom_name: Nausea
  onset_date: '2024-07-24'
  severity: Mild
  outcome: Recovered
  intervention_required: true
  intervention_details: Prescribed right and advised market.
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Negative dechallenge
reporting_facility: Rhodes-Lane Medical Center
reporter_type: Patient
